David A Brinker, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 7601 Osler Dr, Towson, MD 21204 Phone: 410-337-1000 |
Hillary Maren Epstein, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 7601 Osler Dr, Towson, MD 21204 Phone: 410-337-1724 |
Zhen Fan, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 7601 Osler Dr, Towson, MD 21204 Phone: 410-337-1000 |
Steven R Axe, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 7601 Osler Dr, Towson, MD 21204 Phone: 410-337-1000 |
Fowza Taqi, M.D. Pathology - Cytopathology Medicare: Not Enrolled in Medicare Practice Location: 7601 Osler Dr, Towson, MD 21204 Phone: 410-377-1000 |
James W Eagan Jr., M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 7601 Osler Dr, Towson, MD 21204 Phone: 410-337-1000 |
Dr. Clarence D Miller, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 1026 Green Acre Rd, Towson, MD 21286 Phone: 410-821-1673 |
News Archive
Legislation in Congress would boost Medicare payment rates for some doctors who claim they are are routinely underpaid for services in California. Meanwhile hearings in South Dakota focus on Medicare reimbursement issues in rural areas.
A breakthrough in basic research and the first comprehensive study on the secretory activity of the human intestine: over a period of eight years, Dr. Dagmar Krüger of the Department of Human Biology at TU Munich has examined more than 2200 specimens from around 450 patients with bowel disease.
While video gaming is generally perceived as a pastime for children and young adults, research shows that the average age of players in the United States is 35.
A Rice University researcher has won a prestigious federal grant to study how a recently identified protein in the cornea aids development, homeostasis and wound healing in the eye.
Imprimis Pharmaceuticals, Inc., which is focused on the commercialization of compounded drug formulations utilizing the FDA 505(b)(2) development pathway, today announced it has received IRB approval for its Phase III clinical trial protocol of its lead product candidate, Impracor.
› Verified 6 days ago